Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022

Loading...
Loading...

Upgrades

  • Morgan Stanley upgraded the previous rating for Pure Storage Inc PSTG from Equal-Weight to Overweight. In the second quarter, Pure Storage showed an EPS of $0.32, compared to $0.14 from the year-ago quarter. The current stock performance of Pure Storage shows a 52-week-high of $36.71 and a 52-week-low of $21.89. Moreover, at the end of the last trading period, the closing price was at $30.50.
  • According to Oppenheimer, the prior rating for Biomarin Pharmaceutical Inc BMRN was changed from Perform to Outperform. In the third quarter, Biomarin Pharmaceutical showed an EPS of $0.04, compared to $0.20 from the year-ago quarter. The current stock performance of Biomarin Pharmaceutical shows a 52-week-high of $97.76 and a 52-week-low of $70.73. Moreover, at the end of the last trading period, the closing price was at $86.77.
  • Barclays upgraded the previous rating for Intel Corp INTC from Underweight to Equal-Weight. For the third quarter, Intel had an EPS of $0.59, compared to year-ago quarter EPS of $1.71. The current stock performance of Intel shows a 52-week-high of $56.28 and a 52-week-low of $24.59. Moreover, at the end of the last trading period, the closing price was at $29.07.
  • According to Barclays, the prior rating for Gilead Sciences Inc GILD was changed from Underweight to Equal-Weight. In the third quarter, Gilead Sciences showed an EPS of $1.90, compared to $2.65 from the year-ago quarter. The stock has a 52-week-high of $79.61 and a 52-week-low of $57.16. At the end of the last trading period, Gilead Sciences closed at $79.27.
  • JP Morgan upgraded the previous rating for TrueCar Inc TRUE from Underweight to Overweight. TrueCar earned $0.12 in the second quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.08 and a 52-week-low of $1.30. TrueCar closed at $1.52 at the end of the last trading period.

See all analyst ratings upgrades.

 

Downgrades

  • Oppenheimer downgraded the previous rating for Ayala Pharmaceuticals Inc AYLA from Outperform to Perform. Ayala Pharmaceuticals earned $0.54 in the second quarter, compared to $0.75 in the year-ago quarter. The current stock performance of Ayala Pharmaceuticals shows a 52-week-high of $9.40 and a 52-week-low of $0.57. Moreover, at the end of the last trading period, the closing price was at $0.69.
  • Roth Capital downgraded the previous rating for Argo Blockchain PLC ARBK from Neutral to Sell. Argo Blockchain earned $0.82 in the second quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.14 and a 52-week-low of $1.37. Argo Blockchain closed at $1.97 at the end of the last trading period.
  • According to Raymond James, the prior rating for Aon PLC AON was changed from Market Perform to Underperform. Aon earned $2.02 in the third quarter, compared to $1.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $341.98 and a 52-week-low of $246.21. Aon closed at $289.20 at the end of the last trading period.
  • According to Wells Fargo, the prior rating for Hanesbrands Inc HBI was changed from Overweight to Underweight. In the second quarter, Hanesbrands showed an EPS of $0.28, compared to $0.47 from the year-ago quarter. At the moment, the stock has a 52-week-high of $17.55 and a 52-week-low of $6.91. Hanesbrands closed at $7.20 at the end of the last trading period.
  • According to Wedbush, the prior rating for Y-mAbs Therapeutics Inc YMAB was changed from Outperform to Neutral. For the second quarter, Y-mAbs Therapeutics had an EPS of $0.94, compared to year-ago quarter EPS of $0.53. At the moment, the stock has a 52-week-high of $20.48 and a 52-week-low of $6.50. Y-mAbs Therapeutics closed at $8.93 at the end of the last trading period.
  • For Advanced Micro Devices Inc AMD, Northland Capital Markets downgraded the previous rating of Outperform to Market Perform. For the second quarter, Advanced Micro Devices had an EPS of $1.05, compared to year-ago quarter EPS of $0.63. The stock has a 52-week-high of $152.42 and a 52-week-low of $54.57. At the end of the last trading period, Advanced Micro Devices closed at $62.01.
  • For Cedar Fair LP FUN, Credit Suisse downgraded the previous rating of Outperform to Neutral. Cedar Fair earned $0.89 in the second quarter, compared to $1.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $62.56 and a 52-week-low of $37.78. Cedar Fair closed at $41.00 at the end of the last trading period.
  • According to Barclays, the prior rating for Amgen Inc AMGN was changed from Equal-Weight to Underweight. For the second quarter, Amgen had an EPS of $4.65, compared to year-ago quarter EPS of $4.38. The stock has a 52-week-high of $274.54 and a 52-week-low of $214.39. At the end of the last trading period, Amgen closed at $273.81.
  • Barclays downgraded the previous rating for LyondellBasell Industries NV LYB from Overweight to Equal-Weight. In the third quarter, LyondellBasell Industries showed an EPS of $1.96, compared to $5.25 from the year-ago quarter. At the moment, the stock has a 52-week-high of $117.22 and a 52-week-low of $71.46. LyondellBasell Industries closed at $77.99 at the end of the last trading period.
  • For Texas Roadhouse Inc TXRH, Deutsche Bank downgraded the previous rating of Buy to Hold. Texas Roadhouse earned $0.93 in the third quarter, compared to $0.75 in the year-ago quarter. At the moment, the stock has a 52-week-high of $100.37 and a 52-week-low of $68.58. Texas Roadhouse closed at $98.71 at the end of the last trading period.
  • For Honeywell International Inc HON, Daiwa Capital downgraded the previous rating of Outperform to Neutral. Honeywell Intl earned $2.25 in the third quarter, compared to $2.02 in the year-ago quarter. The current stock performance of Honeywell Intl shows a 52-week-high of $221.89 and a 52-week-low of $166.63. Moreover, at the end of the last trading period, the closing price was at $204.93.
  • For Keurig Dr Pepper Inc KDP, Truist Securities downgraded the previous rating of Hold to Sell. For the third quarter, Keurig Dr Pepper had an EPS of $0.46, compared to year-ago quarter EPS of $0.44. The current stock performance of Keurig Dr Pepper shows a 52-week-high of $41.31 and a 52-week-low of $33.35. Moreover, at the end of the last trading period, the closing price was at $39.55.
  • UBS downgraded the previous rating for Caterpillar Inc CAT from Buy to Neutral. For the third quarter, Caterpillar had an EPS of $3.95, compared to year-ago quarter EPS of $2.66. The stock has a 52-week-high of $237.90 and a 52-week-low of $160.60. At the end of the last trading period, Caterpillar closed at $219.34.
  • For DaVita Inc DVA, UBS downgraded the previous rating of Buy to Neutral. For the third quarter, DaVita had an EPS of $1.45, compared to year-ago quarter EPS of $2.36. At the moment, the stock has a 52-week-high of $124.81 and a 52-week-low of $69.26. DaVita closed at $70.54 at the end of the last trading period.
  • For Paramount Global PARA, Wells Fargo downgraded the previous rating of Equal-Weight to Underweight. In the second quarter, Paramount Global showed an EPS of $0.64, compared to $0.97 from the year-ago quarter. The current stock performance of Paramount Global shows a 52-week-high of $39.21 and a 52-week-low of $17.93. Moreover, at the end of the last trading period, the closing price was at $19.02.
  • JP Morgan downgraded the previous rating for Reinsurance Group of America Inc RGA from Overweight to Neutral. For the second quarter, Reinsurance Group had an EPS of $5.78, compared to year-ago quarter EPS of $4.00. At the moment, the stock has a 52-week-high of $148.75 and a 52-week-low of $97.61. Reinsurance Group closed at $148.55 at the end of the last trading period.
  • BMO Capital downgraded the previous rating for Sonoco Products Co SON from Market Perform to Underperform. In the second quarter, Sonoco Products showed an EPS of $1.76, compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of $67.06 and a 52-week-low of $51.52. At the end of the last trading period, Sonoco Products closed at $64.86.
  • For Greif Inc GEF, BMO Capital downgraded the previous rating of Market Perform to Underperform. For the third quarter, Greif had an EPS of $2.35, compared to year-ago quarter EPS of $1.93. The stock has a 52-week-high of $72.80 and a 52-week-low of $53.65. At the end of the last trading period, Greif closed at $69.05.

See all analyst ratings downgrades.

 

Initiations

  • Guggenheim initiated coverage on Iovance Biotherapeutics Inc IOVA with a Neutral rating. Iovance Biotherapeutics earned $0.63 in the second quarter, compared to $0.53 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.66 and a 52-week-low of $6.18. Iovance Biotherapeutics closed at $9.75 at the end of the last trading period.
  • With a Buy rating, Guggenheim initiated coverage on Century Therapeutics Inc IPSC. The price target seems to have been set at $15.00 for Century Therapeutics. For the second quarter, Century Therapeutics had an EPS of $0.54, compared to year-ago quarter EPS of $1.93. The current stock performance of Century Therapeutics shows a 52-week-high of $16.83 and a 52-week-low of $7.32. Moreover, at the end of the last trading period, the closing price was at $10.78.
  • With a Buy rating, Guggenheim initiated coverage on Arcellx Inc ACLX. The price target seems to have been set at $36.00 for Arcellx. For the second quarter, Arcellx had an EPS of $0.88, compared to year-ago quarter EPS of $36.42. The current stock performance of Arcellx shows a 52-week-high of $26.91 and a 52-week-low of $6.04. Moreover, at the end of the last trading period, the closing price was at $22.01.
  • For Solid Power Inc SLDP, Cowen & Co. initiated coverage, by setting the current rating at Market Perform. For the second quarter, Solid Power had an EPS of $0.08, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $9.99 and a 52-week-low of $4.58. At the end of the last trading period, Solid Power closed at $5.55.
  • Cowen & Co. initiated coverage on FREYR Battery FREY with an Outperform rating. For the second quarter, FREYR Battery had an EPS of $0.24, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $16.94 and a 52-week-low of $6.42. FREYR Battery closed at $13.02 at the end of the last trading period.
  • BTIG initiated coverage on PROCEPT BioRobotics Corp PRCT with a Neutral rating. PROCEPT BioRobotics earned $0.43 in the second quarter, compared to $2.60 in the year-ago quarter. The current stock performance of PROCEPT BioRobotics shows a 52-week-high of $52.40 and a 52-week-low of $15.38. Moreover, at the end of the last trading period, the closing price was at $45.34.
  • BTIG initiated coverage on Outlook Therapeutics Inc OTLK with a Buy rating. The price target for Outlook Therapeutics is set to $7.00. Outlook Therapeutics earned $0.08 in the third quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $2.12 and a 52-week-low of $0.68. Outlook Therapeutics closed at $1.20 at the end of the last trading period.
  • Jefferies initiated coverage on NetApp Inc NTAP with a Buy rating. The price target for NetApp is set to $88.00. NetApp earned $1.20 in the first quarter, compared to $1.15 in the year-ago quarter. The stock has a 52-week-high of $96.82 and a 52-week-low of $60.56. At the end of the last trading period, NetApp closed at $69.40.
  • With a Equal-Weight rating, Wells Fargo initiated coverage on Veeva Systems Inc VEEV. The price target seems to have been set at $180.00 for Veeva Sys. For the second quarter, Veeva Sys had an EPS of $1.03, compared to year-ago quarter EPS of $0.94. The current stock performance of Veeva Sys shows a 52-week-high of $257.68 and a 52-week-low of $151.02. Moreover, at the end of the last trading period, the closing price was at $171.58.
  • With an Overweight rating, Wells Fargo initiated coverage on Doximity Inc DOCS. The price target seems to have been set at $38.00 for Doximity. In the first quarter, Doximity showed an EPS of $0.14, compared to $0.11 from the year-ago quarter. The current stock performance of Doximity shows a 52-week-high of $64.95 and a 52-week-low of $23.73. Moreover, at the end of the last trading period, the closing price was at $26.31.
  • Guggenheim initiated coverage on 2seventy bio Inc TSVT with a Buy rating. The price target for 2seventy bio is set to $30.00. 2seventy bio earned $2.02 in the second quarter, compared to $3.60 in the year-ago quarter. The current stock performance of 2seventy bio shows a 52-week-high of $27.04 and a 52-week-low of $9.91. Moreover, at the end of the last trading period, the closing price was at $15.24.
  • With a Hold rating, Jefferies initiated coverage on Dell Technologies Inc DELL. The price target seems to have been set at $39.00 for Dell Technologies. Dell Technologies earned $1.68 in the second quarter, compared to $2.24 in the year-ago quarter. The stock has a 52-week-high of $61.54 and a 52-week-low of $32.90. At the end of the last trading period, Dell Technologies closed at $39.16.
  • Keybanc initiated coverage on Bumble Inc BMBL with a Sector Weight rating. Bumble earned $0.03 in the second quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.33 and a 52-week-low of $15.41. Bumble closed at $25.50 at the end of the last trading period.
  • With an Overweight rating, Piper Sandler initiated coverage on Gritstone Bio Inc GRTS. The price target seems to have been set at $6.00 for Gritstone Bio. Gritstone Bio earned $0.34 in the second quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $13.01 and a 52-week-low of $1.71. At the end of the last trading period, Gritstone Bio closed at $2.71.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...